LUCENTIS treats DR and DME

Click on the links below to learn more about diabetic retinopathy (DR), diabetic macular edema (DME) and vascular endothelial growth factor (VEGF)

How may LUCENTIS help with DR and DME?

LUCENTIS is the first and only FDA-approved anti-VEGF medicine for diabetic retinopathy (DR), with or without diabetic macular edema (DME). Talk to your Retina Specialist and ask if LUCENTIS is right for you.

LUCENTIS is available for as little as $5 per injection

To learn more about the LUCENTIS Co-pay Program, call (855) 218-5307 or visit

Terms and conditions apply.*

The LUCENTIS Co-pay Program can help eligible patients with commercial insurance reduce their out-of-pocket costs, regardless of income, up to $10,000 per year of the patient’s co-pay or co-insurance.†  Options are also available regardless of insurance. 

*The LUCENTIS Co-pay Program does not cover costs for any other medication, procedure, or diagnostic test.

In order to be eligible for the LUCENTIS Co-pay Program, you must confirm that you meet the eligibility criteria and agree to the rules set forth in the terms and conditions for the program. Please visit for the full list of terms and conditions.

Patients who are ineligible for the LUCENTIS Co-pay Program may be eligible for other types of patient support. Please call LUCENTIS Access Solutions® at (866) 724-9394 for details.

Patient support for people with DR

Or call 1-866-LUCENTIS (1-866-582-3684), Monday through Friday, 9 am-8 pm ET.

Learn what you may expect for your LUCENTIS treatment